ASCA News and Activities

ASCA is owned by Daiichi Sankyo.

Daiichi Sankyo is one of the...

• Forbes Global 2000 (#653);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Daiichi Sankyo is a company listed under the stock ticker 4568 (JP).

Daiichi Sankyo has a direct presence in 10 countries.

Daiichi Sankyo has 11 subsidiaries including American Regent, ASCA and Daiichi Sankyo Benelux.

They are in:

• Pharmaceuticals92%
• Healthcare8%

View the org chart displaying its 3 main executives

Most searched biographies at ASCA

• Eiko Ishioka, President
• Ayumi Imanaka, Director
• Yoshio Uchida, Director, Business Management Group

Popular executive movements at Daiichi Sankyo

• John Tsai has joined the company as Global Head of Research and Development  (posted on February 20 2026).
• Ken Takeshita, Head of Research & Development Unit, will leave the company on Apr. 1, 2026  (posted on February 20 2026).
• Veronika Rozehnal has joined the company as Head of Translational Research, Center Europe  (posted on January 22 2026).

Create your alert
to follow the executive moves at ASCA.

Daiichi Sankyo has 3,493 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).
• Garner Health has just announced a $100 Million fundraising (posted on May 29 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by ASCA

Social media about ASCA

• ASCA on Wikipedia, Google News & Yahoo Finance
• ASCA on LinkedIn, X (Twitter) & YouTube